- 2.7Impact Factor
- 4.7CiteScore
- 22 daysTime to First Decision
Recent Developments in Artificial Intelligence for Ophthalmology: Advances, Challenges and Future Directions
This special issue belongs to the section “Artificial Intelligence in Healthcare“.
Special Issue Information
Dear Colleagues,
Artificial Intelligence (AI) has emerged as a transformative technology in the field of ophthalmology, enhancing the diagnosis, treatment, and management of various eye diseases. From deep learning applications in retinal imaging to AI-powered surgical assistance, the potential of AI is revolutionizing how ophthalmic care is delivered. The continuous evolution of machine learning, natural language processing (NLP), large language models (LLM), and predictive analytics holds promise for improving patient outcomes, personalized care, and early detection of eye disorders.
This Special Issue invites original research and review articles that focus on clinically relevant AI applications in ophthalmology. We are particularly interested in manuscripts that provide real-world insights into how AI is integrated into clinical workflows, improve patient care, or present emerging tools that are transitioning from development to practical use in healthcare settings.
Submissions that discuss clinical outcomes, patient-centered AI applications, and solutions that enhance ophthalmic practices will be prioritized. Additionally, we encourage contributions that highlight the clinical utility of AI models and the challenges of integrating AI into existing healthcare systems.
Suggested topics include, but are not limited to:
- AI for Retinal Disease Diagnosis
- AI tools clinically applied for detecting diabetic retinopathy and macular degeneration.
- AI-driven screening technologies integrated into ophthalmic care.
- AI advancements in glaucoma diagnosis and progression monitoring.
- Predictive analytics for early glaucoma risk assessment.
- Machine learning models for optimizing cataract surgery outcomes.
- AI-based pre-operative assessment and post-surgical recovery monitoring.
- Deep learning innovations for OCT-based diagnosis of retinal diseases.
- Automated analysis of OCT images using AI for early disease detection.
- AI applications in telemedicine for remote ophthalmic diagnosis and monitoring.
- AI-enhanced teleophthalmology systems for underserved populations.
- Deep learning models for detecting keratoconus and other corneal diseases.
- AI-assisted corneal transplantation planning and post-operative monitoring.
- AI-guided robotic platforms for precision ophthalmic surgeries.
- Machine learning applications for enhancing outcomes in robotic-assisted eye surgeries.
- NLP for automated analysis of ophthalmology medical records and research literature.
- AI-driven decision support systems in ophthalmology using NLP.
- Applications of large language models (LLMs), such as ChatGPT, in ophthalmic research, education, and/or practice.
- Using LLMs for improving ophthalmology consultation services, medical records summarization, and patient care.
- Exploring the role of conversational AI tools in ophthalmology patient education, practice, and/or communication.
- Ethical considerations and practical healthcare solutions to ensure fairness in clinical AI applications.
- Approaches to addressing algorithmic bias in ophthalmic tools and improving equitable patient care.
We look forward to receiving your contributions that will shape the future of AI in ophthalmology, focusing on its clinical relevance and practical implementation in healthcare settings.
Dr. Andrzej Grzybowski
Dr. Polat Goktas
Dr. Kai Jin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- ophthalmology
- retinal disease
- glaucoma
- deep learning
- cataract surgery
- optical coherence tomography (OCT)
- teleophthalmology
- large language models (LLMs)
- ChatGPT
- natural language processing (BLP)
- clinical AI integration
- bias and fairness in AI
- ophthalmic AI applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

